| |
 |
 |
|
|
LUPIN LIMITED
Registered Office: 159, C.S.T. Road, Kalina, Santacruz (East),
Mumbai - 400 098.
UNAUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2008
|
|
(Rs. in Lakhs) |
|
|
|
1) Sales (Gross)
Less: Excise Duty
Sales (Net) |
|
87,917
1,685
86,232 |
59,132
1,559
57,573 |
277,301
6,664
270,637
|
| 2) Other
Income |
2,015
|
1,592
|
20,645
|
| 3) Total
Income |
88,247
|
59,165
|
291,282
|
|
4) Expenditure
|
|
|
|
- Decrease/(Increase) in stock in trade and
work-in-progress
|
5,421
|
(6,141) |
(21,320) |
- Consumption of raw and packing materials
|
25,051
|
21,069 |
101,951 |
- Purchase of traded goods goods
|
6,730
|
8,982 |
35,749 |
|
|
10,136
|
6,368 |
30,760 |
- Depreciation and amortisation
|
1,932
|
1,274 |
6,474 |
- Manufacturing and other expenses
|
23,629
|
19,083 |
79,912 |
|
Total |
72,899
|
50,635 |
233,526 |
| 5 )
Interest and finance charges |
1,018
|
890 |
3,735 |
| 6 )
Exceptional items |
- |
- |
- |
| 7)
Profit from Ordinary Activities before tax |
14,330
|
7,640 |
54,021 |
|
8) Tax Expense |
|
|
|
|
|
2,775
|
1,703 |
12,032 |
|
|
356
|
353 |
1,148 |
| 9) Net
Profit from Ordinary Activities after tax |
11,199
|
5,584 |
40,841 |
| 10)
Extraordinary items (net of tax expense) |
- |
- |
- |
| 11) Net
Profit before minority interest and share of loss in
Associate |
11,199
|
5,584 |
40,841 |
12)
a) Minority Interest
b) Share
of loss in Associate |
(5)
- |
(4)
- |
13
3
|
| 13) Net
profit |
11,204
|
5,588 |
40,825 |
14) Paid
up equity share capital
(Face value Rs.10/- each) |
8,209 |
8,151 |
8,208 |
| 15)
Reserves excluding Revaluation Reserves |
|
|
119,760 |
| 16) Earnings Per Share [EPS] (Not Annualised) Rs. |
13.65
13.58
|
6.94
6.83 |
50.01
49.78
|
|
15)
Public Shareholding
Number of share
Percentage of shareholding
|
40123939
48.88 |
39483028
48.44 |
40117137
48.88 |
| NOTES: |
|
|
|
|
1. The above consolidated financial results were reviewed by the Audit Committee and thereafter approved and taken on record by the Board of Directors at their meeting held on July 22, 2008.
2. The Consolidated Financial Statements include the financial statements of the subsidiaries Lupin Pharmaceuticals Inc.- U.S.A., Kyowa Pharmaceutical Industry Co., Limited -Japan, Novodigm Limited -India, Max Pharma Pty Limited - Australia, Lupin Pharmacare Limited- India, Lupin Australia Pty Limited- Australia, Lupin Holdings B.V.- Netherlands, Lupin Herbal Limited- India, Lupin Atlantis Holdings S.A.- Switzerland and Amel Touhoku-Japan.
3. The Consolidated Financial Statements are prepared in accordance with Accounting Standard 21 "Consolidated Financial Statements" issued by the Institute of Chartered Accountants of India.
4. During the quarter, 6,802 equity shares of Rs.10/- each, fully paid-up were allotted on exercise of the vested stock options in accordance with the terms of exercise under the Lupin Employees Stock Option Plans, thereby resulting in an increase in the paid-up share capital by Rs. 1 lakh and securities premium by Rs. 24 lakhs.
5. The group operates exclusively in the "Pharmaceuticals" business segment and has only one reportable segment. Revenue by geographical segment data is as follows :
|
|
|
|
|
|
|
|
|
|
|
|
Revenue within India |
34,632
|
30,008 |
120,309 |
|
Revenue outside India
|
53,255
|
28,710 |
168,439 |
|
6. There was no unresolved investor complaint pending as on April 01, 2008. The Company received 12 complaints during the quarter which were resolved. There was no unresolved complaint pending as on June 30, 2008.
7. Figures for the previous periods have been regrouped, wherever necessary, to correspond with the figures of the current period.
|
By order of the Board
For Lupin Limited |
Place: Mumbai
Dated: October 24 , 2007 |
Dr. Desh Bandhu Gupta
Chairman |
|
|
| | |
| |
|
|
|